Davide Maestri

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

CRISPR Screens Reveal Epstein-Barr Virus-activated JunB as a Key Lymphoblastoid B cell Dependency Factor that Represses Cyclin Dependent Kinase Inhibitor P18INK4c.

CRISPR Screens Reveal Epstein-Barr Virus-activated JunB as a Key Lymphoblastoid B cell Dependency Factor that Represses Cyclin Dependent Kinase Inhibitor P18INK4c.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Integrated transcriptomic and methylome analysis reveals retinoic acid pathway activation after decitabine treatment in EBV-associated gastric cancer.

Integrated transcriptomic and methylome analysis reveals retinoic acid pathway activation after decitabine treatment in EBV-associated gastric cancer.

Journal: mBio

Published: February 10, 2026

Lamin A/C maintains genome topology and regulates transcriptional programs essential for virus-driven B cell activation.

Lamin A/C maintains genome topology and regulates transcriptional programs essential for virus-driven B cell activation.

Journal: bioRxiv : the preprint server for biology

Published: February 06, 2026

Integrated transcriptomic and methylome analysis reveals retinoic acid pathway activation after decitabine treatment in EBV associated gastric cancer.

Integrated transcriptomic and methylome analysis reveals retinoic acid pathway activation after decitabine treatment in EBV associated gastric cancer.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Epstein-Barr Virus Encoded lncRNAs Control the Viral Lytic Switch.

Epstein-Barr Virus Encoded lncRNAs Control the Viral Lytic Switch.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Histone variant H2A.Z cooperates with EBNA1 to maintain Epstein-Barr virus latent epigenome.

Histone variant H2A.Z cooperates with EBNA1 to maintain Epstein-Barr virus latent epigenome.

Journal: mBio

Published: July 14, 2025

Histone Variant H2A.Z Cooperates with EBNA1 to Maintain Epstein-Barr Virus Latent Epigenome.

Histone Variant H2A.Z Cooperates with EBNA1 to Maintain Epstein-Barr Virus Latent Epigenome.

Journal: bioRxiv : the preprint server for biology

Published: February 20, 2025

PARP1 Inhibition Halts EBV+ Lymphoma Progression by Disrupting the EBNA2/MYC Axis.

PARP1 Inhibition Halts EBV+ Lymphoma Progression by Disrupting the EBNA2/MYC Axis.

Journal: Journal of medical virology

Published: December 17, 2024

Lysine-specific histone demethylase complex restricts Epstein-Barr virus lytic reactivation.

Lysine-specific histone demethylase complex restricts Epstein-Barr virus lytic reactivation.

Journal: Nature microbiology

Published: December 15, 2024

EBNA leader protein orchestrates chromatin architecture remodeling during Epstein-Barr virus-induced B cell transformation.

EBNA leader protein orchestrates chromatin architecture remodeling during Epstein-Barr virus-induced B cell transformation.

Journal: Nucleic acids research

Published: November 27, 2024

Epstein-Barr virus latent membrane protein 1 subverts IMPDH pathways to drive B-cell oncometabolism.

Epstein-Barr virus latent membrane protein 1 subverts IMPDH pathways to drive B-cell oncometabolism.

Journal: PLoS pathogens

Published: November 12, 2024

The DNA loop release factor WAPL suppresses Epstein-Barr virus latent membrane protein expression to maintain the highly restricted latency I program.

The DNA loop release factor WAPL suppresses Epstein-Barr virus latent membrane protein expression to maintain the highly restricted latency I program.

Journal: bioRxiv : the preprint server for biology

Published: May 20, 2024

Showing 1-12 of 54

Last Updated: 09/26/2026